{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:44:47Z","timestamp":1790790287351,"version":"4.1.0"},"reference-count":78,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Amyloidosis is an uncommon but important entity. A protein-based classification of amyloidosis defines the underlying disease process, directing clinical management and providing prognostic information. However, in routine surgical pathology there often is no attempt to classify amyloid other than staining to determine light chain\u2013associated amyloidosis. Systemic and localized amyloidosis vary with respect to frequency of organ involvement by different amyloid types, and most amyloid proteins have commercial antibodies available for identification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To provide a guide for the likelihood of amyloid type by organ system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources.\u2014<\/jats:title>\n                    <jats:p>Literature review based on PubMed searches containing the word amyloid, specifically addressing the prevalence and significance of amyloid proteins in each organ system other than the brain, and the authors' practice experience.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>In patients with amyloidosis, determination of the responsible protein is critical for appropriate patient care. In large subspecialty practices and reference laboratories with experience in using and analyzing relevant immunohistochemistry, most amyloid proteins can be identified with an organ-specific algorithm. Referring to an organ-based algorithm may be helpful in providing clinicians with a more specific differential diagnosis regarding amyloid type to help guide clinical evaluation and treatment. When the protein cannot be characterized, mass spectrometry can be performed to definitively classify the amyloid type.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2018-0509-ra","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T11:05:51Z","timestamp":1573124751000},"page":"379-387","source":"Crossref","is-referenced-by-count":16,"title":["An Organ System\u2013Based Approach to Differential Diagnosis of Amyloid Type in Surgical Pathology"],"prefix":"10.5858","volume":"144","author":[{"given":"Gabriel","family":"Giannini","sequence":"first","affiliation":[{"name":"From the Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia C.","family":"Nast","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"issue":"1","key":"2020081300440182500_i1543-2165-144-3-379-b01","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000444206","article-title":"The prevalence and management of systemic amyloidosis in Western countries","volume":"2","author":"Nienhuis","year":"2016","journal-title":"Kidney Dis (Basel)"},{"issue":"7","key":"2020081300440182500_i1543-2165-144-3-379-b02","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989","volume":"79","author":"Kyle","year":"1992","journal-title":"Blood"},{"issue":"2","key":"2020081300440182500_i1543-2165-144-3-379-b03","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0268-960X(95)90032-2","article-title":"Amyloidosis","volume":"9","author":"Hawkins","year":"1995","journal-title":"Blood Rev"},{"issue":"2","key":"2020081300440182500_i1543-2165-144-3-379-b04","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.proghi.2012.03.001","article-title":"On typing amyloidosis using immunohistochemistry: detailled illustrations, review and a note on mass spectrometry","volume":"47","author":"Linke","year":"2012","journal-title":"Prog Histochem Cytochem"},{"issue":"4","key":"2020081300440182500_i1543-2165-144-3-379-b05","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/13506129.2016.1257986","article-title":"Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines","volume":"23","author":"Sipe","year":"2016","journal-title":"Amyloid"},{"issue":"1","key":"2020081300440182500_i1543-2165-144-3-379-b06","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jacc.2016.04.035","article-title":"Cardiac amyloid load: a prognostic and predictive biomarker in patients with light-chain amyloidosis","volume":"68","author":"Kristen","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2020081300440182500_i1543-2165-144-3-379-b07","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12882-015-0046-0","article-title":"Comparison of amyloid deposition in human kidney biopsies as predictor of poor patient outcome","volume":"16","author":"Castano","year":"2015","journal-title":"BMC Nephrol"},{"issue":"3","key":"2020081300440182500_i1543-2165-144-3-379-b08","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/07853890701206887","article-title":"The workings of the amyloid diseases","volume":"39","author":"Bellotti","year":"2007","journal-title":"Ann Med"},{"issue":"3","key":"2020081300440182500_i1543-2165-144-3-379-b09","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40620-017-0426-6","article-title":"Pathology and diagnosis of renal non-AL amyloidosis","volume":"31","author":"Sethi","year":"2018","journal-title":"J Nephrol"},{"issue":"2","key":"2020081300440182500_i1543-2165-144-3-379-b10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood-2011-06-358507","article-title":"Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients","volume":"119","author":"Sch\u00f6nland","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2020081300440182500_i1543-2165-144-3-379-b11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2016-01-629790","article-title":"What is new in diagnosis and management of light chain amyloidosis?","volume":"128","author":"Palladini","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2020081300440182500_i1543-2165-144-3-379-b12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2169\/internalmedicine.53.0898","article-title":"Clinical manifestations at diagnosis in Japanese patients with systemic AL amyloidosis: a retrospective study of 202 cases with a special attention to uncommon symptoms","volume":"53","author":"Matsuda","year":"2014","journal-title":"Intern Med"},{"issue":"1","key":"2020081300440182500_i1543-2165-144-3-379-b13","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin Hematol"},{"key":"2020081300440182500_i1543-2165-144-3-379-b14","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1186\/1471-2458-12-974","article-title":"Incidence and survival in non-hereditary amyloidosis in Sweden","volume":"12","author":"Hemminki","year":"2012","journal-title":"BMC Public Health"},{"issue":"2-3","key":"2020081300440182500_i1543-2165-144-3-379-b15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12016-009-8163-9","article-title":"Currents concepts on the immunopathology of amyloidosis","volume":"38","author":"Bhat","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"2020081300440182500_i1543-2165-144-3-379-b16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.bmt.1705395","article-title":"Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?","volume":"38","author":"Bahlis","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2020081300440182500_i1543-2165-144-3-379-b17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41408-018-0080-9","article-title":"Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018","volume":"8","author":"Gertz","year":"2018","journal-title":"Blood Cancer J"},{"issue":"2","key":"2020081300440182500_i1543-2165-144-3-379-b18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/joim.12506","article-title":"Current and future treatment of amyloid diseases","volume":"280","author":"Ankarcrona","year":"2016","journal-title":"J Intern Med"},{"issue":"suppl 1","key":"2020081300440182500_i1543-2165-144-3-379-b19","doi-asserted-by":"crossref","first-page":"I8","DOI":"10.1186\/1750-1172-10-S1-I8","article-title":"ATTR-FAP: liver transplantation vs oral medication, how and when","volume":"10","author":"Erikzon","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"2020081300440182500_i1543-2165-144-3-379-b20","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1371","article-title":"Advances in the treatment of hereditary transthyretin amyloidosis: a review","author":"Gertz","year":"2019","journal-title":"Brain Behav."},{"key":"2020081300440182500_i1543-2165-144-3-379-b21","doi-asserted-by":"crossref","unstructured":"Emdin\n              M\n            , AimoA, RapezziC, et al. \n          Treatment of cardiac transthyretin amyloidosis: an update [published online ahead of print May 20, 2019.]. Eur Heart J. doi:10.1093\/eurheartj\/ehz298.","DOI":"10.1093\/eurheartj\/ehz298"},{"issue":"8","key":"2020081300440182500_i1543-2165-144-3-379-b22","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s40265-019-01129-6","article-title":"Tafamidis: a review in transthyretin amyloidosis with polyneuropathy","volume":"79","author":"Lamb","year":"2019","journal-title":"Drugs"},{"key":"2020081300440182500_i1543-2165-144-3-379-b23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/CLEP.S39981","article-title":"Systemic AA amyloidosis: epidemiology, diagnosis, and management","volume":"6","author":"Real de As\u00faa","year":"2014","journal-title":"Clin Epidemiol"},{"issue":"2","key":"2020081300440182500_i1543-2165-144-3-379-b24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00428-001-0582-9","article-title":"Pathology, diagnosis and pathogenesis of AA amyloidosis","volume":"440","author":"R\u00f6cken","year":"2002","journal-title":"Virchows Arch"},{"issue":"4","key":"2020081300440182500_i1543-2165-144-3-379-b25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ndt\/gfv318","article-title":"\u03b22 microglobulin amyloidosis: an update 30 years later","volume":"31","author":"Jadoul","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2020081300440182500_i1543-2165-144-3-379-b26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1525-139X.2006.00134.x","article-title":"Dialysis-related amyloidosis: late finding or hidden epidemic?","volume":"19","author":"Dember","year":"2006","journal-title":"Semin Dial"},{"issue":"3","key":"2020081300440182500_i1543-2165-144-3-379-b27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/sdi.12590","article-title":"Dialysis-related amyloidosis: is it gone or should it be?","volume":"30","author":"Labriola","year":"2017","journal-title":"Semin Dial"},{"issue":"24","key":"2020081300440182500_i1543-2165-144-3-379-b28","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1056\/NEJMoa1201356","article-title":"Hereditary systemic amyloidosis due to Asp76Asn variant \u03b22-microglobulin","volume":"366","author":"Valleix","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"2020081300440182500_i1543-2165-144-3-379-b29","first-page":"241","article-title":"Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis","volume":"33","author":"Rezk","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"2020081300440182500_i1543-2165-144-3-379-b30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ki.2010.9","article-title":"and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies","volume":"77","author":"Larsen","year":"2010","journal-title":"Kidney Int"},{"issue":"10","key":"2020081300440182500_i1543-2165-144-3-379-b31","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2013-07-517938","article-title":"Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States","volume":"123","author":"Mereuta","year":"2014","journal-title":"Blood"},{"issue":"3","key":"2020081300440182500_i1543-2165-144-3-379-b32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2353\/jmoldx.2009.080161","article-title":"Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene","volume":"11","author":"Eriksson","year":"2009","journal-title":"J Mol Diagn"},{"issue":"4","key":"2020081300440182500_i1543-2165-144-3-379-b33","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.kint.2016.11.017","article-title":"Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis","volume":"91","author":"Sethi","year":"2017","journal-title":"Kidney Int"},{"issue":"1","key":"2020081300440182500_i1543-2165-144-3-379-b34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/01.md.0000200467.51816.6d","article-title":"Lysozyme amyloidosis: report of 4 cases and a review of the literature","volume":"85","author":"Granel","year":"2006","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2020081300440182500_i1543-2165-144-3-379-b35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ng0393-252","article-title":"Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain","volume":"3","author":"Benson","year":"1993","journal-title":"Nat Genet"},{"issue":"6","key":"2020081300440182500_i1543-2165-144-3-379-b36","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1053\/j.ajkd.2015.08.016","article-title":"Renal AH amyloidosis associated with a truncated immunoglobulin heavy chain undetectable by immunostaining","volume":"66","author":"Manabe","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"12 suppl 3","key":"2020081300440182500_i1543-2165-144-3-379-b37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3949\/ccjm.84.s3.02","article-title":"Cardiac amyloidosis: an update on diagnosis and treatment","volume":"84","author":"Donnelly","year":"2017","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"2020081300440182500_i1543-2165-144-3-379-b38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cpcardiol.2017.04.003","article-title":"Cardiac amyloidosis: an updated review with emphasis on diagnosis and future directions","volume":"43","author":"Bhogal","year":"2018","journal-title":"Curr Probl Cardiol"},{"issue":"10","key":"2020081300440182500_i1543-2165-144-3-379-b39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11886-017-0911-5","article-title":"Transthyretin cardiac amyloidosis","volume":"19","author":"Mankad","year":"2017","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"2020081300440182500_i1543-2165-144-3-379-b40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pathol.2017.10.012","article-title":"Cardiac amyloidosis: from clinical suspicion to morphological diagnosis","volume":"50","author":"Flodrova","year":"2018","journal-title":"Pathology"},{"issue":"6","key":"2020081300440182500_i1543-2165-144-3-379-b41","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/S2352-3026(15)00068-X","article-title":"Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study","volume":"2","author":"Mahmood","year":"2015","journal-title":"Lancet Haematol"},{"issue":"3","key":"2020081300440182500_i1543-2165-144-3-379-b42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11739-011-0647-y","article-title":"Cardiac amyloidosis: the heart of the matter","volume":"8","author":"Perfetto","year":"2013","journal-title":"Intern Emerg Med"},{"issue":"3","key":"2020081300440182500_i1543-2165-144-3-379-b43","first-page":"391","article-title":"Senile systemic amyloidosis","volume":"117","author":"Pitk\u00e4nen","year":"1984","journal-title":"Am J Pathol"},{"issue":"2","key":"2020081300440182500_i1543-2165-144-3-379-b44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2020081300440182500_i1543-2165-144-3-379-b45","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-3-319-19294-9_29","article-title":"Cardiac amyloidosis","author":"Tan","year":"2015","journal-title":"Amyloid and Related Disorders: Surgical Pathology and Clinical Correlations"},{"key":"2020081300440182500_i1543-2165-144-3-379-b46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-3-319-19294-9_28","article-title":"Amyloidoses of the kidney, the lower urinary and genital tracts (male and female), and the breast","author":"Picken","year":"2015","journal-title":"Amyloid and Related Disorders: Surgical Pathology and Clinical Correlations"},{"issue":"9","key":"2020081300440182500_i1543-2165-144-3-379-b47","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1093\/ndt\/gfq831","article-title":"Renal amyloidosis revisited: amyloid distribution, dynamics and biochemical type","volume":"26","author":"Hopfer","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"2020081300440182500_i1543-2165-144-3-379-b48","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2215\/CJN.10491012","article-title":"Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases","volume":"8","author":"Said","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"2020081300440182500_i1543-2165-144-3-379-b49","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/PAS.0b013e3181abdfa7","article-title":"Prevalence and origin of amyloid in kidney biopsies","volume":"33","author":"von Hutten","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"2020081300440182500_i1543-2165-144-3-379-b50","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1681\/ASN.2008070813","article-title":"Nephrotic syndrome due to an amyloidogenic mutation in fibrinogen A alpha chain","volume":"20","author":"Picken","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"755","key":"2020081300440182500_i1543-2165-144-3-379-b51","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/pgmj.64.755.696","article-title":"Massive macroglossia, amyloidosis and myeloma","volume":"64","author":"Jacobs","year":"1988","journal-title":"Postgrad Med J"},{"issue":"11","key":"2020081300440182500_i1543-2165-144-3-379-b52","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1365-2036.2008.03682.x","article-title":"Review article: gastrointestinal amyloidosis\u2014clinical features, diagnosis and therapy","volume":"27","author":"Petre","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"2020081300440182500_i1543-2165-144-3-379-b53","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.humpath.2014.12.009","article-title":"Gastric amyloidosis: clinicopathological correlations in 79 cases from a single institution","volume":"46","author":"Said","year":"2015","journal-title":"Hum Pathol"},{"issue":"5","key":"2020081300440182500_i1543-2165-144-3-379-b54","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00428-016-1916-y","article-title":"Amyloid in biopsies of the gastrointestinal tract\u2014a retrospective observational study on 542 patients","volume":"468","author":"Freudenthaler","year":"2016","journal-title":"Virchows Arch"},{"issue":"12","key":"2020081300440182500_i1543-2165-144-3-379-b55","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/modpathol.3800477","article-title":"Gastrointestinal beta2microglobulin amyloidosis in hemodialysis patients: biochemical analysis of amyloid proteins in small formalin-fixed paraffin-embedded tissue specimens","volume":"18","author":"Kaplan","year":"2005","journal-title":"Mod Pathol"},{"issue":"3","key":"2020081300440182500_i1543-2165-144-3-379-b56","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jgh.13996","article-title":"Systemic amyloidosis with gastrointestinal involvement: diagnosis from endoscopic and histological views","volume":"33","author":"Iida","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"2020081300440182500_i1543-2165-144-3-379-b57","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.md.0000091183.93122.c7","article-title":"Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients","volume":"82","author":"Park","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"2020081300440182500_i1543-2165-144-3-379-b58","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4254\/wjh.v8.i6.340","article-title":"Primary hepatic amyloidosis: a case report and review of literature","volume":"8","author":"Sonthalia","year":"2016","journal-title":"World J Hepatol"},{"issue":"10","key":"2020081300440182500_i1543-2165-144-3-379-b59","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/MEG.0000000000000695","article-title":"Amyloidosis of the gastrointestinal tract and the liver: clinical context, diagnosis and management","volume":"28","author":"Syed","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"2020081300440182500_i1543-2165-144-3-379-b60","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/PAS.0000000000000373","article-title":"Globular hepatic amyloid is highly sensitive and specific for LECT2 amyloidosis","volume":"39","author":"Chandan","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2020081300440182500_i1543-2165-144-3-379-b61","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/13506129.2017.1301917","article-title":"Transbronchial biopsies safely diagnose amyloid lung disease","volume":"24","author":"Govender","year":"2017","journal-title":"Amyloid"},{"issue":"2","key":"2020081300440182500_i1543-2165-144-3-379-b62","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5858\/arpa.2016-0102-RA","article-title":"Amyloidosis of the lung","volume":"141","author":"Khoor","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"2020081300440182500_i1543-2165-144-3-379-b63","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/ckj\/sft126","article-title":"Leukocyte chemotactic factor 2 (LECT2) amyloidosis presenting as pulmonary-renal syndrome: a case report and review of the literature","volume":"6","author":"Khalighi","year":"2013","journal-title":"Clin Kidney J"},{"issue":"4","key":"2020081300440182500_i1543-2165-144-3-379-b64","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/dc.21023","article-title":"Nodular pulmonary amyloidosis with an unusual protein composition diagnosed by fine-needle aspiration biopsy: a case report","volume":"37","author":"Yang","year":"2009","journal-title":"Diagn Cytopathol"},{"issue":"4","key":"2020081300440182500_i1543-2165-144-3-379-b65","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7326\/0003-4819-124-4-199602150-00004","article-title":"Pulmonary amyloidosis: the Mayo Clinic experience from 1980 to 1993","volume":"124","author":"Utz","year":"1996","journal-title":"Ann Intern Med"},{"issue":"3","key":"2020081300440182500_i1543-2165-144-3-379-b66","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/PAS.0b013e318272fe19","article-title":"Nodular pulmonary amyloidosis is characterized by localized immunoglobulin deposition and is frequently associated with an indolent B-cell lymphoproliferative disorder","volume":"37","author":"Grogg","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"2020081300440182500_i1543-2165-144-3-379-b67","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/thx.48.12.1287","article-title":"Pulmonary nodules due to reactive systemic amyloidosis (AA) in Crohn's disease","volume":"48","author":"Beer","year":"1993","journal-title":"Thorax"},{"issue":"10","key":"2020081300440182500_i1543-2165-144-3-379-b68","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s10067-007-0552-y","article-title":"Nodular pulmonary amyloidosis in a patient with rheumatoid arthritis","volume":"26","author":"Calatayud","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"6","key":"2020081300440182500_i1543-2165-144-3-379-b69","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/msj.21352","article-title":"Amyloid neuropathies","volume":"79","author":"Shin","year":"2012","journal-title":"Mt Sinai J Med"},{"issue":"5","key":"2020081300440182500_i1543-2165-144-3-379-b70","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/WCO.0b013e328357bdf6","article-title":"Amyloid neuropathies","volume":"25","author":"Adams","year":"2012","journal-title":"Curr Opin Neurol"},{"issue":"suppl 1","key":"2020081300440182500_i1543-2165-144-3-379-b71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13506129.2012.685665","article-title":"Regional difference and similarity of familial amyloidosis with polyneuropathy in France","volume":"19","author":"Adams","year":"2012","journal-title":"Amyloid"},{"key":"2020081300440182500_i1543-2165-144-3-379-b72","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/978-3-319-19294-9_31","article-title":"Peripheral nerve amyloidosis","author":"Loavenbruck","year":"2015","journal-title":"Amyloid and Related Disorders: Surgical Pathology and Clinical Correlations"},{"issue":"4","key":"2020081300440182500_i1543-2165-144-3-379-b73","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.berh.2012.07.003","article-title":"Osteo-articular manifestations of amyloidosis","volume":"26","author":"M'bapp\u00e9","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"2020081300440182500_i1543-2165-144-3-379-b74","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jos.2017.05.005","article-title":"Treatment strategy for amyloid hip arthropathy in long-term hemodialysis patients","volume":"22","author":"Fukunishi","year":"2017","journal-title":"J Orthop Sci"},{"issue":"1","key":"2020081300440182500_i1543-2165-144-3-379-b75","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13018-017-0697-6","article-title":"The unresolved problem of beta-2 microglobulin amyloid deposits in the intervertebral discs of long-term dialysis patients","volume":"12","author":"Tsai","year":"2017","journal-title":"J Orthop Surg Res"},{"key":"2020081300440182500_i1543-2165-144-3-379-b76","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-3-319-19294-9_7","article-title":"Localized amyloidoses and amyloidoses associated with aging outside the central nervous system","author":"Westermark","year":"2015","journal-title":"Amyloid and Related Disorders: Surgical Pathology and Clinical Correlations"},{"issue":"1","key":"2020081300440182500_i1543-2165-144-3-379-b77","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/aja.2012.125","article-title":"Incidental seminal vesicle amyloidosis observed in diagnostic prostate biopsies\u2013are routine investigations for systemic amyloidosis warranted?","volume":"15","author":"Yang","year":"2013","journal-title":"Asian J Androl"},{"issue":"8","key":"2020081300440182500_i1543-2165-144-3-379-b78","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/labinvest.3700124","article-title":"Two different types of amyloid deposits\u2014apolipoprotein A-IV and transthyretin\u2014in a patient with systemic amyloidosis","volume":"84","author":"Bergstr\u00f6m","year":"2004","journal-title":"Lab Invest"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/144\/3\/379\/2501125\/arpa_2018-0509-ra.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/144\/3\/379\/2501125\/arpa_2018-0509-ra.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:40:09Z","timestamp":1764790809000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/144\/3\/article-p379.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,7]]},"references-count":78,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,11,7]]},"published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2018-0509-ra","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,7]]}}}